Neuvago is not FDA approved as a medical device
Neuvago is positioned as a general wellness product and is not intended to diagnose, treat, cure, or prevent disease.
Legal / FDA Status
FDA status
This page explains how Neuvago should be understood in relation to the United States Food and Drug Administration (FDA). It is intended to clarify how general wellness positioning differs from medical device regulation and why intended use and responsible communication matter so much.
Key points
General wellness positioning matters
Regulatory treatment depends heavily on intended use and product claims. Neuvago is marketed within a wellness framework rather than a medical treatment framework.
Responsible communication is part of compliance
Clear boundaries around claims, intended use, and product purpose are essential for maintaining a compliant and trustworthy wellness positioning.
Is Neuvago FDA approved?
The U.S. Food and Drug Administration regulates medical devices that are intended to diagnose, treat, cure, or prevent disease.
Because Neuvago is designed and marketed as a general wellness device, it is not positioned as a medical device requiring FDA approval in that sense.
Neuvago does not claim to diagnose or treat medical conditions and is not intended for medical use.
General wellness policy context
The FDA has published guidance related to products positioned as general wellness products. These are products intended to support healthy lifestyle practices without making medical claims.
Examples of general wellness positioning may include technologies related to relaxation, stress support, sleep support, mindfulness, meditation, fitness, and general well-being.
Products in this category are typically treated differently from medical devices when they do not make disease-related claims.
Wellness technology and nervous system support
Neuvago is intended as a consumer wellness technology that supports relaxation, stress support, and nervous system awareness.
The device uses non-invasive auricular stimulation techniques that are widely discussed in scientific and educational contexts related to the autonomic nervous system and stress physiology.
Neuvago is intended for individuals interested in wellness practices that may support relaxation and general well-being.
Not intended for medical treatment
Neuvago devices are not intended to diagnose, treat, cure, or prevent any medical condition.
Individuals experiencing symptoms of illness or medical concerns should consult a licensed healthcare professional.
Responsible marketing
Regulatory classification is strongly influenced by intended use and marketing claims.
Neuvago is marketed as a general wellness device intended to support relaxation, stress support, and autonomic nervous system awareness.
The product is not promoted as a therapy, treatment, or medical intervention.
Safety and product design
Although Neuvago is not positioned as a medical device, it is still intended to be designed with safety and responsible product development in mind.
Consumer wellness technologies must still comply with applicable requirements related to electronics, materials, charging, battery safety, and product safety in the markets where they are sold.
Consult a healthcare professional
Individuals with existing medical conditions, implanted medical devices, or concerns regarding electrical stimulation technologies should consult a healthcare professional before using wellness technologies.
This is especially important when a user is unsure whether a general wellness product is appropriate for their own circumstances.
Related legal pages
Continue with regulatory overview, European compliance, and intended use
Regulatory Information
A broader overview of how Neuvago is classified and how regulatory positioning fits into the general wellness category.
Read regulatory informationCE Compliance
The corresponding Europe-focused page explaining CE conformity and consumer electronics compliance in the European market.
Read CE complianceIntended Use
A clearer explanation of what Neuvago is designed for and how intended use shapes product classification.
Read intended useMedical Disclaimer
The legal disclaimer explaining that Neuvago website content is educational and not medical advice or treatment.
Read medical disclaimerContinue through the broader trust layer
Read intended use, European compliance, or return to the legal hub
FDA status is one part of a broader trust and classification framework that explains how Neuvago is positioned, how product claims are bounded, and how the brand communicates responsibly across different markets.